Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

DR GULVE HOLDING ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   0.3% 0.3% 0.3% 0.3% 0.3% 0.3% 0.3% 0.3%   Bankruptcy risk   1.1% 1.5% 1.3% 1.4% 1.2% 1.2% 8.1% 8.1%   Credit score (0-100)   85 77 78 78 80 82 30 30   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   805.4 94.7 248.8 223.7 584.0 589.8 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   781 1,186 590 405 348 507 0.0 0.0   EBITDA   738 1,144 548 363 306 465 0.0 0.0   EBIT   507 964 368 182 125 282 0.0 0.0   Pre-tax profit (PTP)   3,592.1 4,934.3 4,765.5 216.8 4,362.3 2,545.9 0.0 0.0   Net earnings   3,454.8 4,858.7 4,278.2 717.3 4,050.2 2,350.6 0.0 0.0   Pre-tax profit without non-rec. items   3,592 4,934 4,765 217 4,362 2,546 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   8,416 6,751 6,571 6,390 6,210 6,214 0.0 0.0   Shareholders equity total   20,099 20,658 23,236 22,254 24,604 21,854 17,218 17,218   Interest-bearing liabilities   3,727 5,309 7,360 2,758 2,328 2,009 0.0 0.0   Balance sheet total (assets)   24,503 32,385 31,578 25,650 27,290 24,769 17,218 17,218   Net Debt   -7,991 -6,092 -12,201 -10,304 -10,216 -6,044 -17,218 -17,218     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   781 1,186 590 405 348 507 0.0 0.0   Gross profit growth   1.0% 51.9% -50.2% -31.4% -14.1% 46.0% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   24,503 32,385 31,578 25,650 27,290 24,769 17,218 17,218   Balance sheet change%   13.3% 32.2% -2.5% -18.8% 6.4% -9.2% -30.5% 0.0%   Added value   738.4 1,144.0 548.1 362.6 305.6 465.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -463 -1,845 -361 -361 -361 -179 -6,214 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   64.9% 81.3% 62.3% 45.0% 36.0% 55.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   15.9% 22.5% 19.6% 15.0% 20.6% 11.6% 0.0% 0.0%   ROI %   16.1% 25.3% 21.9% 15.1% 20.7% 11.6% 0.0% 0.0%   ROE %   18.7% 23.8% 19.5% 3.2% 17.3% 10.1% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   82.0% 63.8% 73.6% 86.8% 90.2% 88.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -1,082.2% -532.5% -2,226.1% -2,841.7% -3,343.6% -1,298.7% 0.0% 0.0%   Gearing %   18.5% 25.7% 31.7% 12.4% 9.5% 9.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.2% 32.5% 23.9% 80.3% 43.1% 21.4% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   17.2 2.2 3.7 23.0 35.8 32.7 0.0 0.0   Current Ratio   17.2 2.2 3.7 23.0 35.8 32.7 0.0 0.0   Cash and cash equivalent   11,718.1 11,401.5 19,561.2 13,062.6 12,544.9 8,052.6 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   2,601.6 -1,356.3 -4,475.4 4,006.5 10,065.9 9,201.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   738 1,144 548 363 306 465 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   738 1,144 548 363 306 465 0 0   EBIT / employee   507 964 368 182 125 282 0 0   Net earnings / employee   3,455 4,859 4,278 717 4,050 2,351 0 0